ZEISS Medical Technology has announced the Canadian availability of its advanced VISULAS® Combi laser system, marking a significant milestone in ophthalmic treatment accessibility. The all-in-one laser workstation is now approved by Health Canada, offering Canadian eye care professionals access to a versatile platform that combines photodisruption, photocoagulation, and slit lamp technology in a single device.
The ZEISS VISULAS Combi is designed to streamline clinical workflows by enabling the treatment of various eye conditions—including retina, cataract, and glaucoma—through custom modules and a unified interface. Its space-saving features and integration of multiple laser functionalities eliminate the need for separate systems, thereby enhancing practice efficiency.
A key benefit of the system is that it does not require patient relocation during treatment, reducing time-consuming setup changes and improving both clinical throughput and the overall patient experience.
Hady Saheb, MD, and President of the Canadian Glaucoma Society, praised the innovation:
"As an ophthalmologist committed to delivering the best possible care for my patients, I am excited to see the ZEISS VISULAS Combi in practice. I had the opportunity to use the SLT component in conjunction with the ZEISS FORUM and Imaging Solution, and the experience was seamless. The ability to generate treatment reports automatically—without the need to manually enter every detail—is a time-saver for those using the ZEISS FORUM and Imaging Solution."
The launch has been met with enthusiasm by ZEISS Canada. Abrar Espop, Head of Medical Technology at ZEISS Canada, emphasized the system’s clinical and operational value:
"At ZEISS, we are committed to advancing ophthalmic care by improving clinical efficiency and supporting innovation and education. The ZEISS VISULAS Combi embodies our dedication to empowering clinicians and shaping the future of ophthalmology. With its multi-disciplinary capabilities, the ZEISS VISULAS Combi allows ophthalmologists to see more, do more, and treat more—all with one device."
Espop added that the system replaces the need for multiple devices, additional training, and larger clinical workspaces, making it a future-proof investment for eye care professionals seeking precision and adaptability in a compact platform.
With its expansion into the Canadian market, the ZEISS VISULAS Combi is poised to redefine standards in ophthalmic care. By simplifying treatment processes and prioritizing patient comfort, ZEISS continues to deliver innovations that support both clinical outcomes and patient satisfaction.